Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 115
Published Date: 11 Jan 2024
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Point-of-care Testing (POCT) for Cardiovascular Diseases market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Point-of-care Testing (POCT) for Cardiovascular Diseases industry chain, the market status of Hospital (Based on Immunochromatography, Based on Chemiluminescence Technology), lndependent Testing Organization (Based on Immunochromatography, Based on Chemiluminescence Technology), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Point-of-care Testing (POCT) for Cardiovascular Diseases.
Regionally, the report analyzes the Point-of-care Testing (POCT) for Cardiovascular Diseases markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Point-of-care Testing (POCT) for Cardiovascular Diseases market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Point-of-care Testing (POCT) for Cardiovascular Diseases market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Point-of-care Testing (POCT) for Cardiovascular Diseases industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Based on Immunochromatography, Based on Chemiluminescence Technology).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Point-of-care Testing (POCT) for Cardiovascular Diseases market.
Regional Analysis: The report involves examining the Point-of-care Testing (POCT) for Cardiovascular Diseases market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Point-of-care Testing (POCT) for Cardiovascular Diseases market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Point-of-care Testing (POCT) for Cardiovascular Diseases:
Company Analysis: Report covers individual Point-of-care Testing (POCT) for Cardiovascular Diseases manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Point-of-care Testing (POCT) for Cardiovascular Diseases This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, lndependent Testing Organization).
Technology Analysis: Report covers specific technologies relevant to Point-of-care Testing (POCT) for Cardiovascular Diseases. It assesses the current state, advancements, and potential future developments in Point-of-care Testing (POCT) for Cardiovascular Diseases areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Point-of-care Testing (POCT) for Cardiovascular Diseases market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Point-of-care Testing (POCT) for Cardiovascular Diseases market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Based on Immunochromatography
Based on Chemiluminescence Technology
Based on Biosensor
Based on Colloidal Gold
Others
Market segment by Application
Hospital
lndependent Testing Organization
Major players covered
Roche
Abbott
BioMerieux
Wuhan Easy Diagnosis Biomedicine Co.,ltd.
Guangzhou Wondfo Biotech Co.,Ltd.
Getein Biotech, Inc.
Sinocare Inc
Relia Bioengineering Co., Ltd
Beijing Hotgen Biotech Co.,ltd.
Assure Tech (Hangzhou) Co.,Ltd.
Nanjing Vazyme Biotech Co.,Ltd.
Siemens Healthineers
Danaher
Sansure Biotech Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Point-of-care Testing (POCT) for Cardiovascular Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Point-of-care Testing (POCT) for Cardiovascular Diseases, with price, sales, revenue and global market share of Point-of-care Testing (POCT) for Cardiovascular Diseases from 2019 to 2024.
Chapter 3, the Point-of-care Testing (POCT) for Cardiovascular Diseases competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Point-of-care Testing (POCT) for Cardiovascular Diseases breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Point-of-care Testing (POCT) for Cardiovascular Diseases market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Point-of-care Testing (POCT) for Cardiovascular Diseases.
Chapter 14 and 15, to describe Point-of-care Testing (POCT) for Cardiovascular Diseases sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Point-of-care Testing (POCT) for Cardiovascular Diseases
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Based on Immunochromatography
1.3.3 Based on Chemiluminescence Technology
1.3.4 Based on Biosensor
1.3.5 Based on Colloidal Gold
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 lndependent Testing Organization
1.5 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market Size & Forecast
1.5.1 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (2019-2030)
1.5.3 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price (2019-2030)
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.1.4 Roche Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments/Updates
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.2.4 Abbott Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Abbott Recent Developments/Updates
2.3 BioMerieux
2.3.1 BioMerieux Details
2.3.2 BioMerieux Major Business
2.3.3 BioMerieux Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.3.4 BioMerieux Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 BioMerieux Recent Developments/Updates
2.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
2.4.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Details
2.4.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
2.4.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.4.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
2.5 Guangzhou Wondfo Biotech Co.,Ltd.
2.5.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
2.5.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
2.5.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.5.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
2.6 Getein Biotech, Inc.
2.6.1 Getein Biotech, Inc. Details
2.6.2 Getein Biotech, Inc. Major Business
2.6.3 Getein Biotech, Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.6.4 Getein Biotech, Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Getein Biotech, Inc. Recent Developments/Updates
2.7 Sinocare Inc
2.7.1 Sinocare Inc Details
2.7.2 Sinocare Inc Major Business
2.7.3 Sinocare Inc Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.7.4 Sinocare Inc Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sinocare Inc Recent Developments/Updates
2.8 Relia Bioengineering Co., Ltd
2.8.1 Relia Bioengineering Co., Ltd Details
2.8.2 Relia Bioengineering Co., Ltd Major Business
2.8.3 Relia Bioengineering Co., Ltd Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.8.4 Relia Bioengineering Co., Ltd Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Relia Bioengineering Co., Ltd Recent Developments/Updates
2.9 Beijing Hotgen Biotech Co.,ltd.
2.9.1 Beijing Hotgen Biotech Co.,ltd. Details
2.9.2 Beijing Hotgen Biotech Co.,ltd. Major Business
2.9.3 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.9.4 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
2.10 Assure Tech (Hangzhou) Co.,Ltd.
2.10.1 Assure Tech (Hangzhou) Co.,Ltd. Details
2.10.2 Assure Tech (Hangzhou) Co.,Ltd. Major Business
2.10.3 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.10.4 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
2.11 Nanjing Vazyme Biotech Co.,Ltd.
2.11.1 Nanjing Vazyme Biotech Co.,Ltd. Details
2.11.2 Nanjing Vazyme Biotech Co.,Ltd. Major Business
2.11.3 Nanjing Vazyme Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.11.4 Nanjing Vazyme Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Nanjing Vazyme Biotech Co.,Ltd. Recent Developments/Updates
2.12 Siemens Healthineers
2.12.1 Siemens Healthineers Details
2.12.2 Siemens Healthineers Major Business
2.12.3 Siemens Healthineers Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.12.4 Siemens Healthineers Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Siemens Healthineers Recent Developments/Updates
2.13 Danaher
2.13.1 Danaher Details
2.13.2 Danaher Major Business
2.13.3 Danaher Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.13.4 Danaher Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Danaher Recent Developments/Updates
2.14 Sansure Biotech Inc.
2.14.1 Sansure Biotech Inc. Details
2.14.2 Sansure Biotech Inc. Major Business
2.14.3 Sansure Biotech Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
2.14.4 Sansure Biotech Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Sansure Biotech Inc. Recent Developments/Updates
3.1 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Manufacturer (2019-2024)
3.2 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Manufacturer (2019-2024)
3.3 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Point-of-care Testing (POCT) for Cardiovascular Diseases by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Point-of-care Testing (POCT) for Cardiovascular Diseases Manufacturer Market Share in 2023
3.4.2 Top 6 Point-of-care Testing (POCT) for Cardiovascular Diseases Manufacturer Market Share in 2023
3.5 Point-of-care Testing (POCT) for Cardiovascular Diseases Market: Overall Company Footprint Analysis
3.5.1 Point-of-care Testing (POCT) for Cardiovascular Diseases Market: Region Footprint
3.5.2 Point-of-care Testing (POCT) for Cardiovascular Diseases Market: Company Product Type Footprint
3.5.3 Point-of-care Testing (POCT) for Cardiovascular Diseases Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market Size by Region
4.1.1 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Region (2019-2030)
4.1.2 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Region (2019-2030)
4.1.3 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price by Region (2019-2030)
4.2 North America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value (2019-2030)
4.3 Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value (2019-2030)
4.4 Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value (2019-2030)
4.5 South America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value (2019-2030)
4.6 Middle East and Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value (2019-2030)
5.1 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2019-2030)
5.2 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Type (2019-2030)
5.3 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price by Type (2019-2030)
6.1 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2019-2030)
6.2 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Application (2019-2030)
6.3 Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price by Application (2019-2030)
7.1 North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2019-2030)
7.2 North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2019-2030)
7.3 North America Point-of-care Testing (POCT) for Cardiovascular Diseases Market Size by Country
7.3.1 North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Country (2019-2030)
7.3.2 North America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2019-2030)
8.2 Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2019-2030)
8.3 Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Market Size by Country
8.3.1 Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Country (2019-2030)
8.3.2 Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Market Size by Region
9.3.1 Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2019-2030)
10.2 South America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2019-2030)
10.3 South America Point-of-care Testing (POCT) for Cardiovascular Diseases Market Size by Country
10.3.1 South America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Country (2019-2030)
10.3.2 South America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Market Size by Country
11.3.1 Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Point-of-care Testing (POCT) for Cardiovascular Diseases Market Drivers
12.2 Point-of-care Testing (POCT) for Cardiovascular Diseases Market Restraints
12.3 Point-of-care Testing (POCT) for Cardiovascular Diseases Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Point-of-care Testing (POCT) for Cardiovascular Diseases and Key Manufacturers
13.2 Manufacturing Costs Percentage of Point-of-care Testing (POCT) for Cardiovascular Diseases
13.3 Point-of-care Testing (POCT) for Cardiovascular Diseases Production Process
13.4 Point-of-care Testing (POCT) for Cardiovascular Diseases Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Point-of-care Testing (POCT) for Cardiovascular Diseases Typical Distributors
14.3 Point-of-care Testing (POCT) for Cardiovascular Diseases Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 6. Roche Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Roche Recent Developments/Updates
Table 8. Abbott Basic Information, Manufacturing Base and Competitors
Table 9. Abbott Major Business
Table 10. Abbott Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 11. Abbott Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Abbott Recent Developments/Updates
Table 13. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 14. BioMerieux Major Business
Table 15. BioMerieux Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 16. BioMerieux Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. BioMerieux Recent Developments/Updates
Table 18. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
Table 20. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 21. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
Table 23. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 25. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 26. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 28. Getein Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Getein Biotech, Inc. Major Business
Table 30. Getein Biotech, Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 31. Getein Biotech, Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Getein Biotech, Inc. Recent Developments/Updates
Table 33. Sinocare Inc Basic Information, Manufacturing Base and Competitors
Table 34. Sinocare Inc Major Business
Table 35. Sinocare Inc Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 36. Sinocare Inc Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sinocare Inc Recent Developments/Updates
Table 38. Relia Bioengineering Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Relia Bioengineering Co., Ltd Major Business
Table 40. Relia Bioengineering Co., Ltd Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 41. Relia Bioengineering Co., Ltd Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Relia Bioengineering Co., Ltd Recent Developments/Updates
Table 43. Beijing Hotgen Biotech Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Beijing Hotgen Biotech Co.,ltd. Major Business
Table 45. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 46. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
Table 48. Assure Tech (Hangzhou) Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Assure Tech (Hangzhou) Co.,Ltd. Major Business
Table 50. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 51. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
Table 53. Nanjing Vazyme Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Nanjing Vazyme Biotech Co.,Ltd. Major Business
Table 55. Nanjing Vazyme Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 56. Nanjing Vazyme Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Nanjing Vazyme Biotech Co.,Ltd. Recent Developments/Updates
Table 58. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 59. Siemens Healthineers Major Business
Table 60. Siemens Healthineers Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 61. Siemens Healthineers Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Siemens Healthineers Recent Developments/Updates
Table 63. Danaher Basic Information, Manufacturing Base and Competitors
Table 64. Danaher Major Business
Table 65. Danaher Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 66. Danaher Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Danaher Recent Developments/Updates
Table 68. Sansure Biotech Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Sansure Biotech Inc. Major Business
Table 70. Sansure Biotech Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Product and Services
Table 71. Sansure Biotech Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Sansure Biotech Inc. Recent Developments/Updates
Table 73. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 74. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Manufacturer (2019-2024) & (USD Million)
Table 75. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 76. Market Position of Manufacturers in Point-of-care Testing (POCT) for Cardiovascular Diseases, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 77. Head Office and Point-of-care Testing (POCT) for Cardiovascular Diseases Production Site of Key Manufacturer
Table 78. Point-of-care Testing (POCT) for Cardiovascular Diseases Market: Company Product Type Footprint
Table 79. Point-of-care Testing (POCT) for Cardiovascular Diseases Market: Company Product Application Footprint
Table 80. Point-of-care Testing (POCT) for Cardiovascular Diseases New Market Entrants and Barriers to Market Entry
Table 81. Point-of-care Testing (POCT) for Cardiovascular Diseases Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Region (2019-2024) & (K Units)
Table 83. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Region (2025-2030) & (K Units)
Table 84. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Region (2019-2024) & (USD Million)
Table 85. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Region (2025-2030) & (USD Million)
Table 86. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price by Region (2019-2024) & (US$/Unit)
Table 87. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price by Region (2025-2030) & (US$/Unit)
Table 88. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price by Type (2019-2024) & (US$/Unit)
Table 93. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price by Type (2025-2030) & (US$/Unit)
Table 94. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 97. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 98. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price by Application (2019-2024) & (US$/Unit)
Table 99. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price by Application (2025-2030) & (US$/Unit)
Table 100. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2019-2024) & (K Units)
Table 101. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2025-2030) & (K Units)
Table 102. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2019-2024) & (K Units)
Table 103. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2025-2030) & (K Units)
Table 104. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Country (2019-2024) & (K Units)
Table 105. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Country (2025-2030) & (K Units)
Table 106. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 107. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2019-2024) & (K Units)
Table 109. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2025-2030) & (K Units)
Table 110. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2019-2024) & (K Units)
Table 111. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2025-2030) & (K Units)
Table 112. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Country (2019-2024) & (K Units)
Table 113. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Country (2025-2030) & (K Units)
Table 114. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 115. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 116. Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2019-2024) & (K Units)
Table 117. Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2025-2030) & (K Units)
Table 118. Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2019-2024) & (K Units)
Table 119. Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2025-2030) & (K Units)
Table 120. Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Region (2019-2024) & (K Units)
Table 121. Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Region (2025-2030) & (K Units)
Table 122. Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Region (2019-2024) & (USD Million)
Table 123. Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Region (2025-2030) & (USD Million)
Table 124. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2019-2024) & (K Units)
Table 125. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2025-2030) & (K Units)
Table 126. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2019-2024) & (K Units)
Table 127. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2025-2030) & (K Units)
Table 128. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Country (2019-2024) & (K Units)
Table 129. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Country (2025-2030) & (K Units)
Table 130. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 131. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 132. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2019-2024) & (K Units)
Table 133. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Type (2025-2030) & (K Units)
Table 134. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2019-2024) & (K Units)
Table 135. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Application (2025-2030) & (K Units)
Table 136. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Region (2019-2024) & (K Units)
Table 137. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Region (2025-2030) & (K Units)
Table 138. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Region (2019-2024) & (USD Million)
Table 139. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Region (2025-2030) & (USD Million)
Table 140. Point-of-care Testing (POCT) for Cardiovascular Diseases Raw Material
Table 141. Key Manufacturers of Point-of-care Testing (POCT) for Cardiovascular Diseases Raw Materials
Table 142. Point-of-care Testing (POCT) for Cardiovascular Diseases Typical Distributors
Table 143. Point-of-care Testing (POCT) for Cardiovascular Diseases Typical Customers
List of Figures
Figure 1. Point-of-care Testing (POCT) for Cardiovascular Diseases Picture
Figure 2. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share by Type in 2023
Figure 4. Based on Immunochromatography Examples
Figure 5. Based on Chemiluminescence Technology Examples
Figure 6. Based on Biosensor Examples
Figure 7. Based on Colloidal Gold Examples
Figure 8. Others Examples
Figure 9. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share by Application in 2023
Figure 11. Hospital Examples
Figure 12. lndependent Testing Organization Examples
Figure 13. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (2019-2030) & (K Units)
Figure 16. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price (2019-2030) & (US$/Unit)
Figure 17. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Point-of-care Testing (POCT) for Cardiovascular Diseases by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Point-of-care Testing (POCT) for Cardiovascular Diseases Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Point-of-care Testing (POCT) for Cardiovascular Diseases Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price by Type (2019-2030) & (US$/Unit)
Figure 32. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price by Application (2019-2030) & (US$/Unit)
Figure 35. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share by Region (2019-2030)
Figure 55. China Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Point-of-care Testing (POCT) for Cardiovascular Diseases Market Drivers
Figure 76. Point-of-care Testing (POCT) for Cardiovascular Diseases Market Restraints
Figure 77. Point-of-care Testing (POCT) for Cardiovascular Diseases Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Cardiovascular Diseases in 2023
Figure 80. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Cardiovascular Diseases
Figure 81. Point-of-care Testing (POCT) for Cardiovascular Diseases Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Roche Abbott BioMerieux Wuhan Easy Diagnosis Biomedicine Co.,ltd. Guangzhou Wondfo Biotech Co.,Ltd. Getein Biotech, Inc. Sinocare Inc Relia Bioengineering Co., Ltd Beijing Hotgen Biotech Co.,ltd. Assure Tech (Hangzhou) Co.,Ltd. Nanjing Vazyme Biotech Co.,Ltd. Siemens Healthineers Danaher Sansure Biotech Inc.
Related Reports
24 Feb 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
